the aid library

Filter

10696

Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis

Singh-Phulgenda, S., Dahal, P., Ngu, R. PLOS Neglected Tropical Diseases (2021) C1

Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ... more

Population mobility and malaria

World Health Organization ( WHO), Regional Oﬃce for South-East-Asia (2017) C_WHO

Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul ... more

Medidas decisivas de preparación, disposición a la acción y respuesta frente a la COVID-19
recommended

World Health Organization WHO (2020) C_WHO

Orientations provisoires, 4 novembre 2020

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ... socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives more

Participant’s manual: Integrated Disease Surveillance and Response Liberia

Ministry of Health and Social Welfare, Liberia; World Health Organization (WHO) (2016) C_WHO

Note d’orientation de l’OMS : tests de diagnostic de la COVID-19

Organisation Mondiale de la Santé OMS (2022) C_WHO

Les notes d’orientation exposent les mesures essentielles que les décideurs peuvent mettre en œuvre aux niveaux national et infranational pour les éléments suivants : tests de diagnostic de la COVID-19, prise en charge clinique de la COVID-19, atteinte des cibles en matière de vaccination con ... more

Malaria Entomology And Vector Control - Tutor Guide

World Health Organization (2013) C_WHO

Training module

Prevención de las infecciones nosocomiales

Organización Mundial de la Salud (2002)

Counseling the Obstetric Fistula Client

EngenderHealthFistuale Care (2012)

A Trainings Curriculum

Social resistance drives persistent transmission of Ebola virus disease in Eastern Democratic Republic of Congo: A mixed-methods study

Masumbuko ClaudeK, Underschultz J,Hawkes MT (2019) CC

PLoSONE 14(9):e0223104.https://doi.org/10.1371/journal.pone.0223104. The survey centering on reasons behind community resistance was conducted in Butembo in November during a time of Ebola transmission. A researcher from Catholic University of Graben in Butembo and collaborators at the University o ... more

community-based rehabilitation: CBR guidelines - Education component

Kamala Achu, Kathy Al Jubah, Svein Brodtkorb, WHO (2010) C_WHO

Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek http://www.who.int/disabilities/cbr/guidelines/en/

Community-based rehabilitation: CBR guidelines - Empowerment component
recommended

Kamala Achu, Kathy Al Jubah, Svein Brodtkorb, WHO (2010) C_WHO

Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek http://www.who.int/disabilities/cbr/guidelines/en/

Basic malaria microscopy. Part 1: Learner's guide
recommended

World Health Organization (2020) C_WHO

second edition

PIH Guide to the Medical Management of MDR-TB

USAID; TB Care; DRTB Training Network (2014) C1

This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
recommended

Schieffelin, JS.; J.G. Shaffer; A. Goba, et al. (2014)

Rahmenkonzept Ebolafieber. Vorbereitungen auf Maßnahmen in Deutschland (Stand: 31.5.2018)

Robert-Koch-Institut (2015) C1

Das Dokument soll dem Erkennen, Bewerten und Bewältigen des Auftretens von Ebolafieber in Deutschland dienen und richtet sich dabei primär an den öffentlichen Gesundheitsdienst sowie medizinisches Fachpersonal in der klinischen, ambulanten und rettungsdienstlichen Versorgung in Deutschland. Es is ... more

Guidelines for Diagnosis and Management of Childhood Epilepsy

Expert Committee on Pediatric Epilepsy, Indian Academy of Pediatrics Indian Pediatrics (2009) CC

Seizures constitute the most common neurological problem in children and the majority of epilepsy has its onset in childhood. Appropriate diagnosis and management of childhood epilepsy is essential to improve quality of life in these children. Evidence-based clinical practice guidelines, modified to ... more

The Primary Care Innovator’s Handbook
recommended

The Center for Health Market Innovations. (2015) C1

Voices from Leaders in the Field

Ebola Virus Disease in Africa: Epidemiology and health facility related transmission

Shears, Paul, T.J.D. O'Dempsey (2015)

A review of current literature and up date data from the field, April 2015. This report has been published in part in J Hosp Inf. 2015;90:1-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=ebola+nosocomial+shears